Diversified Healthcare Trust

Diversified Healthcare Trust(DHC)股票分析

$7.740

-0.039 (-0.51%)收盘时

Loading chart…
最高
7.830
开盘
7.800
成交量加权均价
7.73
成交量
1.50M
市值
714.69M
最低
7.620
成交额
11.60M
企业价值/息税折旧摊销前利润(TTM)
16.70

Diversified Healthcare Trust is a real estate investment trust (REIT). The Company is focused on owning healthcare properties located throughout the United States. It has an approximately $7.2 billion portfolio, which includes over 367 properties in 36 states and Washington, D.C., occupied by approximately 450 tenants, and totaling approximately 8.0 million square feet of life science and medical office properties and more than 27,000 senior living units. The Company's segments include Medical Office and Life Science Portfolio and SHOP. Its Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical-related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents.

AI 分析 of Diversified Healthcare Trust (DHC)

持有

Diversified Healthcare Trust (DHC) is currently priced at $7.74, which is below the analyst price targets of $8 and $10.50, indicating potential upside. However, the company has reported a negative net income of $43.3 million in Q1 2026 and has a low RSI of 47.34, suggesting it is neither overbought nor oversold. The recent earnings report showed a slight miss with an EPS of $0.13 against an estimate of $0.15, which may dampen investor sentiment. The significant insider buying trend of 22486.75% over the last quarter indicates confidence from insiders, but the overall market sentiment remains cautious due to the company's low attractiveness rating among small-cap REITs. Therefore, while there is potential for growth, the risks associated with its financial performance and market perception suggest holding rather than buying at this time.

估值指标

Diversified Healthcare Trust(DHC)当前预期市盈率为 16.64,5 年平均预期市盈率为 -2.70。

预期市盈率

严重高估
5 年均值 P/E
-2.70
当前P/E
16.64
高估
-0.65
低估
-4.76

预期 EV/EBITDA

严重高估
5 年均值 EV/EBITDA
13.66
当前EV/EBITDA
16.70
高估
14.60
低估
12.72

预期市销率

严重高估
5 年均值 P/S
0.41
当前P/S
1.21
高估
0.51
低估
0.31

Alphio AI 对 DHC 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%DHC

$3.10

情景价格

基

基准

基准 · 50%DHC

$2.89

情景价格

悲

悲观

悲观 · 25%DHC

$2.50

情景价格

持有 DHC 的大户

S

Silver Point Capital, L.P.

+ 持有DHC

-2.95%

3个月收益率

事件时间线

2026-11-02 (ET)

17:00:00

DHC Reports Q3 Revenue of $367.7M, Down Year-over-Year

2026-10-12 (ET)

08:30:00

RMR Group Facilitates $272.1M Loan Financing

2026-10-06 (ET)

08:30:00

Diversified Healthcare Trust Signs 15-Year Lease with Ensign Group

2026-09-21 (ET)

16:30:00

Industrial Logistics Properties Trust Appoints Anthony Paula as CFO

2026-08-03 (ET)

17:00:00

Q1 Revenue at $365.39M, Below Consensus of $370.76M

资讯

DHC 常见问题 —— 由 Alphio AI 解答

Diversified Healthcare Trust is a real estate investment trust (REIT). The Company is focused on owning healthcare properties located throughout the United States. It has an approximately $7.2 billion portfolio, which includes over 367 properties in 36 states and Washington, D.C., occupied by approximately 450 tenants, and totaling approximately 8.0 million square feet of life science and medical office properties and more than 27,000 senior living units. The Company's segments include Medical Office and Life Science Portfolio and SHOP. Its Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical-related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents. It operates in the Real Estate sector (REAL ESTATE INVESTMENT TRUSTS industry).

Diversified Healthcare Trust (DHC) is currently priced at $7.74, which is below the analyst price targets of $8 and $10.50, indicating potential upside. However, the company has reported a negative net income of $43.3 million in Q1 2026 and has a low RSI of 47.34, suggesting it is neither overbought nor oversold. The recent earnings report showed a slight miss with an EPS of $0.13 against an estimate of $0.15, which may dampen investor sentiment. The significant insider buying trend of 22486.75% over the last quarter indicates confidence from insiders, but the overall market sentiment remains cautious due to the company's low attractiveness rating among small-cap REITs. Therefore, while there is potential for growth, the risks associated with its financial performance and market perception suggest holding rather than buying at this time.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易